DrugDashboards

Memantine Hydrochloride

Memantine Hydrochloride Oral · MEMANTINE HYDROCHLORIDE 2 mg/mL · Solution · Oral · Seton Pharmaceuticals

NDC 13925-0540-12 · 360 mL in 1 BOTTLE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price is down 8% over the past year, to $0.3908 per mL. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.3908per MLinvoice-surveyed acquisition cost · Jun 17, 2026
  • Medicaid generic ceiling (FUL)$0.3971per MLweighted avg manufacturer price $0.1882 · Sep 1, 2025102% of what pharmacies pay — higher than 57% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.25$0.5$0.75Apr 2024Sep 2026$0.3908
28 price points · per ML · held since Jun 17, 2026 · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Medicaid spend (2024)

$13,936
57 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for memantine hydrochloride (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA210319
TE code
AA
Approval date
Aug 31, 2020
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Memantine Hydrochloride Oral (Solution)

LabelerStrengthFirst seenLast seen
Seton PharmaceuticalsMEMANTINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Memantine Hydrochloride — NDC 13925-0540-12," retrieved September 3, 2026, https://drugdashboards.com/drug/13925054012.

Free to cite with attribution — see how the data is put together.